Clinical Study of Fangbai Granule on Reducing Recurrence of Vitiligo

Phase 1

• Conditions: Vitiligo

• Registration Number: ITMCTR2200005607
• Lead Sponsor: Chongqing Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1)18 years old = age =65 years old ;
(2) The stability of non segmental vitiligo patients with vitiligo in plateau (2021 edition) in diagnosis and treatment of vitiligo consensus: ?VIDA to 0 points;?clinical features: a white spot in porcelain white, edge clear or pigmentation.?no isomorphic response (1 year) or higher;?Wood lamp: skin color is white, the boundary is clear, Wood light skin area or less visual area;Non segmental vitiligo vitiligo (reference 2012 global consensus conference) : including the distributing type, hair, face acromegaly and mucous membrane.Distributing type refers to the white spot 2 pieces or more, covers an area of 1 ~ 3 level;Pan hair is white spot size 4 (> 50%);Surface acromegaly type refers to the white spot is mainly limited to the head, limbs, especially in remote and facial toes around the mouth cavity, can for the development of distributed type, hair style;Mucous membrane type refers to the white spot in two or more mucous membrane, can for the development of distributed type, hair style;
(3) Per patient has three white spots at least ,and the white spot restores 75 % than the initial lesions by the wood lamp;
(4) Signed informed consent;

Exclusion Criteria

(1) Pregnant and lactation women;
(2) For treatment of drug allergies;
(3) Need to patients with long-term exposure to the sun;
(4) Cannot with visitors for a long time;
(5) Assessed by the doctor think that don't fit into the group of patients (complicated by severe infection, tumor, other autoimmune diseases, serious cardiovascular disease, kidney disease, etc.).
(6) Refused to sign a consent form.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
White spot activity score (VIDA);White spot area;White spot color score (VASI);

Secondary Outcome Measures

Name	Time	Method
The quality of life score (DLQI);